Pricing Log in Create free account
Friday 6 November 2026 Export AMLX’s income statement to Excel — free account

Amylyx Pharmaceuticals, Inc.

AMLX Healthcare Drug Manufacturers Specialty & Generic

Amylyx Pharmaceuticals, Inc.’s revenue for fiscal 2024 (year ended December 2024) was $87.4 million, down 77.1% from fiscal 2023.

Revenue
−100.6%
EPS
+15.2%
Free cash flow
−24.5%

Quarter to June 2026, against a year earlier

27.79 1.61 −5.48%
Market cap
$3.5B
P/E
0.0×
Fwd P/E
−9.2×
Dividend yield
—
F-score
3/9
Altman Z
−2.95
Beneish M
n/a
Dividend safety
n/a
Overview
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios

Amylyx Pharmaceuticals, Inc. (AMLX) Book value per share

Alert me on Book value per share

Amylyx Pharmaceuticals, Inc.'s book value per share at the end of fiscal 2025 was 3.2×, up 33.5% from 2.4× in fiscal 2024. At the end of the quarter to 30 June 2026 it was 2.2×. Over the past ten years it has ranged from 0.9× (fiscal 2020) to 13.4× (fiscal 2021); the current reading is higher than 50% of that period. Amylyx Pharmaceuticals, Inc. ranks 37th of 84 Drug Manufacturers Specialty & Generic companies by book value per share.

Book value per share, annual

Embed this chart

Annual newest first

Period Book value per share Change
FY2025 3.2× 33.50%
FY2024 2.4× (62.49%)
FY2023 6.4× 10.71%
FY2022 5.8× (56.51%)
FY2021 13.4× 1,424.76%
FY2020 0.9× —

Quarterly newest first

Period Book value per share Change
Jun 2026 2.2× (12.94%)
Mar 2026 2.5× (23.46%)
Dec 2025 3.2× (9.25%)
Sep 2025 3.6× 88.88%
19 more quarters

Against its own ten years

Low 0.9× High 13.4×
Ten-year median 4.5×
Current reading's percentile 50

Book value per share against peers

Company Book value per share
PBH Prestige Consumer Healthcare Inc. compare 40.9×
PRGO Perrigo Company plc compare 17.5×
TRLV Trulieve Cannabis Corp. compare 4.0×
LQDA Liquidia Corporation compare 2.2×
AMLX Amylyx Pharmaceuticals, Inc. 2.2×
HIMS Hims & Hers Health, Inc. compare 1.4×
HCM HUTCHMED (China) Limited Sponsored ADR compare 0.0×
RGC Regencell Bioscience Holdings Limited compare 0.0×
SUPN Indivior Pharmaceuticals Inc. compare −0.5×

What Book value per share is

BV per Share tells an investor how much of a company’s accounting net worth stands behind each share.

(Shareholders Equity (Total) ÷ Shares (Basic, Weighted))

The full definition of Book value per share →

More on AMLX